Hyppää sisältöön
    • Suomeksi
    • In English
  • Suomeksi
  • In English
  • Kirjaudu
Näytä aineisto 
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
JavaScript is disabled for your browser. Some features of this site may not work without it.

Dose–response relationship between obstructive sleep apnoea severity and C-reactive protein levels: data from the European Sleep Apnoea Database

Grote, Ludger; Gouveris, Haralampos; Lethuillier, Lea; Verbraecken, Johan; Basoglu, Ozen K.; Schiza, Sophia; Ludka, Ondrej; Ryan, Silke; Joppa, Pavol; Fanfulla, Francesco; Mihaicuta, Stefan; Saaresranta, Tarja; Sliwinski, Pawel; Hedner, Jan; Pepin, Jean Louis; Bailly, Sebastien; ESADA Study Group

Dose–response relationship between obstructive sleep apnoea severity and C-reactive protein levels: data from the European Sleep Apnoea Database

Grote, Ludger
Gouveris, Haralampos
Lethuillier, Lea
Verbraecken, Johan
Basoglu, Ozen K.
Schiza, Sophia
Ludka, Ondrej
Ryan, Silke
Joppa, Pavol
Fanfulla, Francesco
Mihaicuta, Stefan
Saaresranta, Tarja
Sliwinski, Pawel
Hedner, Jan
Pepin, Jean Louis
Bailly, Sebastien
ESADA Study Group
Katso/Avaa
ERJ Open Res-2026-Grote-00707-2025.pdf (965.8Kb)
Lataukset: 

European Respiratory Society (ERS)
doi:10.1183/23120541.00707-2025
URI
https://doi.org/10.1183/23120541.00707-2025
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe202601279291
Tiivistelmä

Introduction

Obstructive sleep apnoea (OSA) characterised by intermittent hypoxia promotes systemic inflammation. This study evaluated the association between OSA severity and circulating C-reactive protein (CRP) levels as marker of systemic inflammation in a pan-European patient cohort.

Methods

This cross-sectional analysis of the multicentre European Sleep Apnoea Database (ESADA) cohort used inverse probability weighted regression adjustment for multiple covariates within a linear mixed-effects model (LMEM) to test the independent association between OSA severity and CRP levels. Covariates included anthropometrics and comorbidities. Study centre and year of analysis accounted for methodological variability in CRP analysis.

Results

18 445 subjects (71% male, median age 53 years (interquartile range 44–62), median apnoea–hypopnoea index (AHI) 22.1 events per h (9–44.9)) were included. CRP (median 3.0 mg·L−1 (1.2–5.1)) increased in a dose–response fashion across OSA severity categories (2.0 (1.0–4.0) for AHI <5 events per h; 2.5 (1.0–5.0) for AHI 5–<15 events per h); 2.9 (1.2–5.0) for AHI 15–<30 events per h; and 3.7 mg·L−1 (1.8–6.4) for AHI ≥30 events per h; p<0.001, respectively). In the final LMEM model, AHI remained an independent predictor of CRP concentration (p<0.001). Other significant predictors of CRP were age and female sex. Obesity (body mass index ≥35 kg·m−2) had, among other comorbidities, the strongest independent effect on CRP levels with 2.7 mg·L−1 (95% CI 2.45–2.90).

Conclusions

Our results showed a consistent and robust dose–response relationship between OSA severity and systemic inflammation independent of usual confounders. The combination of OSA and obesity amplified the association. Future studies should address whether elevated CRP could serve as a prognostic marker for subsequent cardiovascular events in OSA.

Kokoelmat
  • Rinnakkaistallenteet [29337]

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste
 

 

Tämä kokoelma

JulkaisuajatTekijätNimekkeetAsiasanatTiedekuntaLaitosOppiaineYhteisöt ja kokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste